The University of Queensland

Targeting CEP55 in triple-negative breast cancer (2022–2025)

Grant type:

United States Congressionally Directed Medical Research Programs - Breast Cancer Research Program

Researchers:

• 

  Professor David Fairlie

  NHMRC Leadership Fellow and Group L
  

  Institute for Molecular Bioscience

Funded by:

United States Department of Defense